U.S. Liquid Biopsy Market to 2032
Overview
The U.S. Liquid Biopsy Market is expected to reach a 3.59 USD Billion by 2032 and is projected to grow at a CAGR of 16.72% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.09
Forecast, 2032 (USD Billion)
3.59
CAGR, 2024 - 2032
16.72%
Report Coverage
North America
U.S. Liquid Biopsy Market 2018-2032 USD Billion
U.S. Liquid Biopsy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.09 USD Billion
- Projected Market Size (2032): 3.59 USD Billion
- CAGR (2025-2032): 16.72%
Key Findings of U.S. Liquid Biopsy Market
- The U.S. Liquid Biopsy Market was valued at 1.09 USD Billion in 2024.
- The U.S. Liquid Biopsy Market is likely to grow at a CAGR of 16.72% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Cancer Applications in Application Segment accounted for the largest share of the market with a revenue of 0.83 USD Billion
- The fastest growing segment Routine Screening in Clinical Application Segment grew Fastest with a CAGR of 19.50% during the forecast period from 2024 to 2032.
U.S. Liquid Biopsy Market Scope
U.S. Liquid Biopsy Market Segmentation & Scope
Distribution Channel
- Others
- Third Party Distributor
- Direct Tender
End User
- Others
- Clinics
- Research Centres and Academic Institutes
- Diagnostics Centers
- Reference Laboratories
- Hospitals
Technology
- Microarrays
- Nanotechnology
- Microfluidics-Based
- Immunoassays & Mass Spectrometry
- Polymerase Chain Reaction (PCR)-Based
- Next-Generation Sequencing (NGS)
Clinical Application
- Others
- Patient Work-Up
- Recurrence Monitoring
- Treatment Monitoring
- Therapy Selection
- Routine Screening
Application
- Non-Cancer Applications
- Cancer Applications
Analytical Type
- Histology/Imaging
- Proteomic
- Molecular
Product
- Services & Software
- Instruments
- Consumables & Accessories
Sample Type
- Tissue Fluid
- Pleural Fluid
- Cerebrospinal Fluid (CSF)
- Others
- Saliva Fluid
- Urine Sample-Based
- Blood Sample-Based
Biomaker Type
- Others
- Extracellular Vesicles
- Exosomes
- Cell-Free RNA
- Circulating Cell-Free DNA (cfDNA)
- Circulating Tumor Cells (CTCs)
U.S. Liquid Biopsy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2024 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.09 USD Billion |
| Market Value in 2032 | 3.59 USD Billion |
| CAGR (2025-2032) | 16.72% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Technology,Clinical Application,Application,Analytical Type,Product,Sample Type,Biomaker Type |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 1.09 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,090.76 USD Million in 2024.
Segments and Scope
-
U.S. Liquid Biopsy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in U.S. Liquid Biopsy Market to 2032 with a revenue of 707.08 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in U.S. Liquid Biopsy Market to 2032 with a Growth rate of 17.30 % in forecast period 2025-2032.
-
U.S. Liquid Biopsy Market to 2032, By End User
- Hospitals is the largest segment in U.S. Liquid Biopsy Market to 2032 with a revenue of 571.62 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in U.S. Liquid Biopsy Market to 2032 with a Growth rate of 17.55 % in forecast period 2025-2032.
-
U.S. Liquid Biopsy Market to 2032, By Technology
- Next-Generation Sequencing (NGS) is the largest segment in U.S. Liquid Biopsy Market to 2032 with a revenue of 491.28 USD Billion in the year 2024.
- Nanotechnology is the Fastest growing segment in U.S. Liquid Biopsy Market to 2032 with a Growth rate of 16.74 % in forecast period 2025-2032.
-
U.S. Liquid Biopsy Market to 2032, By Clinical Application
- Routine Screening is the largest segment in U.S. Liquid Biopsy Market to 2032 with a revenue of 420.87 USD Billion in the year 2024.
- Routine Screening is the Fastest growing segment in U.S. Liquid Biopsy Market to 2032 with a Growth rate of 19.50 % in forecast period 2025-2032.
-
U.S. Liquid Biopsy Market to 2032, By Application
- Cancer Applications is the largest segment in U.S. Liquid Biopsy Market to 2032 with a revenue of 834.04 USD Billion in the year 2024.
- Cancer Applications is the Fastest growing segment in U.S. Liquid Biopsy Market to 2032 with a Growth rate of 17.15 % in forecast period 2025-2032.
-
U.S. Liquid Biopsy Market to 2032, By Analytical Type
- Molecular is the largest segment in U.S. Liquid Biopsy Market to 2032 with a revenue of 595.90 USD Billion in the year 2024.
- Molecular is the Fastest growing segment in U.S. Liquid Biopsy Market to 2032 with a Growth rate of 17.40 % in forecast period 2025-2032.
-
U.S. Liquid Biopsy Market to 2032, By Product
- Consumables & Accessories is the largest segment in U.S. Liquid Biopsy Market to 2032 with a revenue of 551.65 USD Billion in the year 2024.
- Consumables & Accessories is the Fastest growing segment in U.S. Liquid Biopsy Market to 2032 with a Growth rate of 17.53 % in forecast period 2025-2032.
-
U.S. Liquid Biopsy Market to 2032, By Sample Type
- Blood Sample-Based is the largest segment in U.S. Liquid Biopsy Market to 2032 with a revenue of 572.62 USD Billion in the year 2024.
- Blood Sample-Based is the Fastest growing segment in U.S. Liquid Biopsy Market to 2032 with a Growth rate of 17.93 % in forecast period 2025-2032.
-
U.S. Liquid Biopsy Market to 2032, By Biomaker Type
- Circulating Tumor Cells (CTCs) is the largest segment in U.S. Liquid Biopsy Market to 2032 with a revenue of 554.13 USD Billion in the year 2024.
- Circulating Tumor Cells (CTCs) is the Fastest growing segment in U.S. Liquid Biopsy Market to 2032 with a Growth rate of 17.68 % in forecast period 2025-2032.
U.S. Liquid Biopsy Market Company Share Analysis
U.S. Liquid Biopsy Market Geographical Sales Distribution, 2018-2032 USD Billion
U.S. Liquid Biopsy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Liquid Biopsy Market is segmented based on Segmentation Distribution Channel,End User,Technology,Clinical Application,Application,Analytical Type,Product,Sample Type,Biomaker Type.
U.S. Liquid Biopsy Market was valued at USD 1.09(Revenue in USD Billion) in 2024.
U.S. Liquid Biopsy Market is projected to grow at a CAGR of 16.72% during the forecast period of 2024 to 2032.
The Cancer Applications segment is expected to dominate the U.S. Liquid Biopsy Market, holding a largest market share of 0.83 USD Billion in 2024
Coming Soon....
U.S. Liquid Biopsy Market Scope
U.S. Liquid Biopsy Market Segmentation & Scope
Distribution Channel
- Others
- Third Party Distributor
- Direct Tender
End User
- Others
- Clinics
- Research Centres and Academic Institutes
- Diagnostics Centers
- Reference Laboratories
- Hospitals
Technology
- Microarrays
- Nanotechnology
- Microfluidics-Based
- Immunoassays & Mass Spectrometry
- Polymerase Chain Reaction (PCR)-Based
- Next-Generation Sequencing (NGS)
Clinical Application
- Others
- Patient Work-Up
- Recurrence Monitoring
- Treatment Monitoring
- Therapy Selection
- Routine Screening
Application
- Non-Cancer Applications
- Cancer Applications
Analytical Type
- Histology/Imaging
- Proteomic
- Molecular
Product
- Services & Software
- Instruments
- Consumables & Accessories
Sample Type
- Tissue Fluid
- Pleural Fluid
- Cerebrospinal Fluid (CSF)
- Others
- Saliva Fluid
- Urine Sample-Based
- Blood Sample-Based
Biomaker Type
- Others
- Extracellular Vesicles
- Exosomes
- Cell-Free RNA
- Circulating Cell-Free DNA (cfDNA)
- Circulating Tumor Cells (CTCs)
Frequently Asked Questions
The U.S. Liquid Biopsy Market is segmented based on Segmentation Distribution Channel,End User,Technology,Clinical Application,Application,Analytical Type,Product,Sample Type,Biomaker Type.
U.S. Liquid Biopsy Market was valued at USD 1.09(Revenue in USD Billion) in 2024.
U.S. Liquid Biopsy Market is projected to grow at a CAGR of 16.72% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Liquid Biopsy Market for final year is USD 3.59 (USD Billion).
U.S. Liquid Biopsy Market Company Profiling
Frequently Asked Questions
The U.S. Liquid Biopsy Market is segmented based on Segmentation Distribution Channel,End User,Technology,Clinical Application,Application,Analytical Type,Product,Sample Type,Biomaker Type.
U.S. Liquid Biopsy Market was valued at USD 1.09(Revenue in USD Billion) in 2024.
U.S. Liquid Biopsy Market is projected to grow at a CAGR of 16.72% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Liquid Biopsy Market for final year is USD 3.59 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.